Inclusion completed

A multicenter, multinational, Phase II study to evaluate Pertuzumab in combination with Trastuzumab and standard neoadjuvant Anthracycline-based chemotherapy in patients with HER2-positive, locally advanced, inflammatory or early-stage breast cancer

Cancer type: Breast cancer

Phase: II

Principal Investigator: Haug Åse

Country: NO

Keywords: Norway, Bergen

Status: Inclusion completed

Link to